Multibagger Update: This pharmaceutical company received a supply order worth Rs 600 crore!

Shares of the company have jumped more than 80 per cent in the last six months.

On February 28, 2023, Vaishali Pharma Limited informed in the exchange filing that the company have received a supply order worth USD 73.85 million (Rs 600 crore) from an overseas buyer for the purchase of antibiotics pharmaceutical products. The order is to be executed within 6 to 8 months.

Vaishali Pharma Limited has delivered multibagger returns to its shareholders in one year. During this period, the company’s share price jumped from Rs 60.45 on March 2, 2022, to Rs 181.05 on March 1, 2023, an increase of more than 190 per cent in one year holding period. 

The company deals in pharmaceutical formulations, APIs, surgical products, and veterinary supplements. It is operating both in domestic and export markets. In domestic markets, it is majorly into trading of APIs whereas, in export markets, it is into trading and marketing of APIs, formulations, surgical products and others.

Today, the stock opened at Rs 186, with a high and low of Rs 186.30 and Rs 181.05. The stock closed trading at Rs 181.05, down by 1.36 per cent.  The stock has a 52-week high of Rs 193.75 and a 52-week low of Rs 51.45.

In the last 6 months, the shares of the company have given more than 80 per cent returns and on a YTD basis, the stock has given about 28 per cent returns.